With the formal adoption of the EU Pharma Package on the horizon, DALILA’s next event takes a focused look at what the reform means in practice \u2013 covering its current status, selected regulatory deep dives, and how the industry is preparing for the changes ahead.<\/p>\r\n
Programme:<\/strong> Participation is free of charge for DALILA members (registration fee of 200 DKK applies to non-DALILA members). Herved indkaldes til ordin\u00e6r generalforsamling i Danish Life Science Law Association til afholdelse<\/p>\r\n fredag den 29. maj 2026 kl. 9:00 Tilmeld dig her.<\/span><\/a><\/p>\r\n Vedtagelseskrav, forslag og fuldmagt<\/strong> Forslag, der \u00f8nskes behandlet p\u00e5 generalforsamlingen, skal sendes til foreningen pr. e-mail til Helene Jensen, Danske Advokater, til hej@danskeadvokater.dk mindst 2 uger f\u00f8r afholdelse af generalforsamlingen. S\u00e5fremt der indkommer forslag, der \u00f8nskes behandlet p\u00e5 generalforsamlingen, fremsendes disse tillige med revideret dagsorden til medlemmerne senest 1 uge f\u00f8r generalforsamlingen.<\/p>\r\n P\u00e5 generalforsamlingen kan der stemmes ved skriftlig fuldmagt. Et medlem kan dog h\u00f8jest stemme med 2 fuldmagter. Medlemmer der \u00f8nsker at stemme ved skriftlig fuldmagt bedes give besked pr. e-mail til Helene Jensen, Danske Advokater, til hej@danskeadvokater.dk, senest fredag den 22. maj 2026.<\/p>\r\n Bilag<\/strong> Kommende arrangementer Dalila event From Reform to Reality: Understanding the EU Pharma Package 18 June 2026 With the formal adoption of the EU Pharma Package on the horizon, DALILA’s next event takes a focused look at what the reform means in practice \u2013 covering its current status, selected regulatory deep dives, and how the industry […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-288","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.dalila.dk\/en\/wp-json\/wp\/v2\/pages\/288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dalila.dk\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.dalila.dk\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.dalila.dk\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dalila.dk\/en\/wp-json\/wp\/v2\/comments?post=288"}],"version-history":[{"count":88,"href":"https:\/\/www.dalila.dk\/en\/wp-json\/wp\/v2\/pages\/288\/revisions"}],"predecessor-version":[{"id":1064,"href":"https:\/\/www.dalila.dk\/en\/wp-json\/wp\/v2\/pages\/288\/revisions\/1064"}],"wp:attachment":[{"href":"https:\/\/www.dalila.dk\/en\/wp-json\/wp\/v2\/media?parent=288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
14.30\u201314.45 Arrival
14.45\u201314.50 Welcome \u2013 Chair of DALILA
14.50\u201315.35 Session 1: EU Pharma Reform in Practice: Status, Transition, and Your Next Steps \u2013 Marc Martens, Partner, Co-Head of Bird & Bird\u2019s International Life Sciences & Healthcare Group (Bird & Bird, Brussels)
15.35-15.45 Break
15.45\u201316.30 Session 2: Selected EU Pharma Reform Topics Under the Microscope: Regulatory Exclusivities, Supply Obligations and the Bolar Exemption \u2013 Clarissa Junge-Gierse, Senior Counsel, (Bird & Bird, Germany)
16.30\u201316.40 Break
16.40\u201317.25 Session 3: A further session will round out the programme, offering insights into how the sector is responding to and preparing for the new regulatory landscape \u2013 further details to follow
17.25\u201317.30 Closing remarks \u2013 Chair of DALILA
17.30\u201319.30 Networking over drinks and tapas
Practical details
\ud83d\udce3 Where: Bird & Bird (Kalkbr\u00e6nderil\u00f8bskaj 8, Copenhagen)
\ud83d\udcc6 When: 18 June 2026 between 14.30-17.30, followed by drinks & tapas
Registration: Click here<\/a><\/p>\r\n
It is the expectation that the event will fulfil the Danish requirements for mandatory training for lawyers, and a certificate of participation will be sent to all registrants after the seminar.
There will be a photographer taking photos at the event for DALILA\u2019s LinkedIn profile and for the website. You can let the photographer know if you would prefer not to have your picture taken.<\/p>\r\nGeneralforsamling fredag den 29. maj kl. 9.00<\/h3>\r\n
hos Kromann Reumert, Sundkrogsgade 5, 2100 K\u00f8benhavn \u00d8 med f\u00f8lgende dagsorden:<\/p>\r\n\r\n
I henhold til vedt\u00e6gternes \u00a7 5 v\u00e6lges bestyrelsen for et \u00e5r ad gangen. Genvalg af et bestyrelsesmedlem kan finde sted.
P\u00e5 den ordin\u00e6re generalforsamling i 2026 stiller Oliver Machholdt, Allan Normann, Ania Pacyk Nielsen, Anne Nymand, David Elkan, Emilie Lerstr\u00f8m, Jakob Krag Nielsen, Mette-Marie Henrichsen, Mette-Marie Uggerh\u00f8j Folden, Mikkel Buhl, Sandra Sobfeldt, og Ulrik Bangsbo Hansen op til genvalg, mens Christoffer Ege Andersen ikke genopstiller. Bestyrelsen stiller desuden forslag om valg af Jacob Fossar Petersen og Jakob Dolmer til bestyrelsen.<\/li>\r\n
Bestyrelsen foresl\u00e5r genvalg af BUUS Jensen Statsautoriserede Revisorer.<\/li>\r\n
Vedtagelse p\u00e5 generalforsamlingen af dagsordenens punkter kan ske med simpelt flertal.<\/p>\r\n
\u00c5rsregnskab 2025<\/a><\/span>
Budget 2026-2027<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"